Engimmune Therapeutics
Latest round
- Seed
Last raised
- May 2022
Total raised
- $16M
Investors
- 2
About Engimmune Therapeutics
In 2021, the company was co-founded by Dr. Rodrigo Vazquez-Lombardii, who serves as the company CSO, Prof. Sai Reddy, who serves as Chairman of the Scientific Advisory Board (SAB), and Dr. Søren Mouritsen, who serves as the CEO of the company. Dominik Escher (Pureos) and Dr. Jørgen Sorberg Petersen (Novo) as directors in the company. The company operates as a medical research company, developing medical methodologies to address the multiple challenges affecting the TCR-based therapeutic discovery and development process, offering innovative high-throughput solutions to TCR engineering and safety screening. The company's platform technology combines three methods in the life science field -- genome editing, deep sequencing and machine learning.
Who invested in Engimmune Therapeutics
2 investors across 1 round
See all investors in Engimmune Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
May 3, 2022
Amount
$16M
Investors
Questions about Engimmune Therapeutics
Who invested in Engimmune Therapeutics?
Engimmune Therapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Engimmune Therapeutics raised?
Engimmune Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Engimmune Therapeutics last raise money?
Engimmune Therapeutics's most recent round on record is a Seed, in May 2022.
What does Engimmune Therapeutics do?
In 2021, the company was co-founded by Dr.
Where is Engimmune Therapeutics headquartered?
Engimmune Therapeutics is headquartered in Basel, Switzerland.
Which VCs invest in companies like Engimmune Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Engimmune Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Engimmune Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.